Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Novartis India
Novartis India
BSE: 500672NSE: NOVARTINDISIN: INE234A01025

8th-Aug-2019 15:22Source: BSE

Novartis India - Results For The Quarter Ended On June 30, 2019

Dear Sir/ Madam,

Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday, August 8, 2019 ("said meeting"), inter alia considered and approved the Unaudited Financial Results of the Company for the quarter ended on June 30, 2019.

The said Meeting commenced at 11:00 a.m. and concluded at 2:45 p.m.

Further, in terms of the applicable provisions of SEBI Listing Regulations, please find enclosed herewith:
a. the Unaudited Financial Results;
b. Limited Review Report dated August 8, 2019, issued by the Statutory Auditors of the Company with respect to the Unaudited Financial Results and taken on record by the Board of Directors of the Company.

The above is for your information and the same is also available on the Company''s website i.e. www.novartis.in

Board Meeting (Novartis India)

Meeting Date

Remark

2019-11-08

Quarterly Results

Sections
Follow us on
Available On
PCI DSS Compliant